Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HKSE:02427's EV-to-FCF is ranked worse than 100% of 100
companies
in the Medical Diagnostics & Research industry
Industry Median: 25.91
vs HKSE:02427: -259.65
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Guanze Medical Information Industry (Holding) Co (HKSE:02427) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Guanze Medical Information Industry (Holding) Co's PE Ratio (TTM) for today is calculated as:
Guanze Medical Information Industry (Holding) Co's share price for today is HK$2.80.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Guanze Medical Information Industry (Holding) Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-0.033.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Guanze Medical Information Industry (Holding) Co EV-to-FCF Related Terms
Guanze Medical Information Industry (Holding) Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guanze Medical Information Industry (Holding) Co EV-to-FCF Chart
Guanze Medical Information Industry (Holding) Co Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Guanze Medical Information Industry (Holding) Co EV-to-FCF vs Medical Diagnostics & Research Industry
Guanze Medical Information Industry (Holding) Co's current Enterprise Value is HK$2,651.04 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Guanze Medical Information Industry (Holding) Co's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2025 was HK$-10.21 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Guanze Medical Information Industry (Holding) Co (HKSE:02427) has a EV-to-FCF of -259.65 as of Jul. 26, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Guanze Medical Information Industry (Holding) Co and its competitors. According to the industry distribution chart, Guanze Medical Information Industry (Holding) Co ranks #999999 out of 100 companies in the Medical Diagnostics & Research industry.
Is Guanze Medical Information Industry (Holding) Co's EV-to-FCF too high?
Guanze Medical Information Industry (Holding) Co's current EV-to-FCF is -259.65. Based on the distribution chart, Guanze Medical Information Industry (Holding) Co ranks #999999 out of 100 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Guanze Medical Information Industry (Holding) Co has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Guanze Medical Information Industry (Holding) Co's EV-to-FCF compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Guanze Medical Information Industry (Holding) Co ranks #999999 out of 100 companies for EV-to-FCF. This places Guanze Medical Information Industry (Holding) Co in the lower half of its industry. The industry median EV-to-FCF is 25.91. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Diagnostics & Research company?
The median EV-to-FCF among Medical Diagnostics & Research companies is 25.91, based on 100 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Guanze Medical Information Industry (Holding) Co and its competitors. For the Medical Diagnostics & Research industry, the median EV-to-FCF is 25.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Guanze Medical Information Industry (Holding) Co's current EV-to-FCF is -259.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guanze Medical Information Industry (Holding) Co stock overvalued right now?
Based on GuruFocus' analysis, Guanze Medical Information Industry (Holding) Co (HKSE:02427) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.28, compared to a current price of HK$2.80 — trading 900% above its estimated fair value. The current EV-to-FCF is -259.65. Guanze Medical Information Industry (Holding) Co's overall GF Score™ is 52/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Guanze Medical Information Industry (Holding) Co (HKSE:02427), the current EV-to-FCF is -259.65 as of Jul. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Guanze Medical Information Industry (Holding) Co (HKSE:02427) Overvalued in 2026?
Based on GuruFocus' analysis, Guanze Medical Information Industry (Holding) Co stock appears to be overvalued.
The current stock price of HK$2.80 is trading 900% above its estimated GF Value™ of HK$0.28.
GuruFocus considers Guanze Medical Information Industry (Holding) Co to be Significantly Overvalued.
Key valuation signals for HKSE:02427:
EV-to-FCF: -259.65
GF Value™: HK$0.28 vs. price of HK$2.80 (900% above fair value)
No single metric tells the full story. See the HKSE:02427 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Guanze Medical Information Industry (Holding) Co Business Description
Guanze Medical Information Industry (Holding) Co Ltd is a medical imaging solutions provider, principally engaged in providing medical imaging film products and medical imaging cloud services in Shandong Province. The company generates the majority of its revenue from the PRC.
52GF Score
Get the complete analysis for HKSE:02427
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02427 has been successfully added to your 
